RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 79 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $761,000 | -75.4% | 30,567 | -79.8% | 0.00% | -100.0% |
| Q2 2021 | $3,090,000 | +5730.2% | 151,446 | +6046.3% | 0.00% | – |
| Q1 2021 | $53,000 | -75.0% | 2,464 | -61.6% | 0.00% | – |
| Q4 2020 | $212,000 | +430.0% | 6,418 | +263.6% | 0.00% | – |
| Q3 2020 | $40,000 | -32.2% | 1,765 | -34.4% | 0.00% | – |
| Q2 2020 | $59,000 | -30.6% | 2,689 | -27.3% | 0.00% | – |
| Q4 2019 | $85,000 | +93.2% | 3,697 | +83.5% | 0.00% | – |
| Q3 2019 | $44,000 | +2.3% | 2,015 | +3.7% | 0.00% | – |
| Q2 2019 | $43,000 | – | 1,943 | +194200.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 216 | +105.7% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 105 | +20.7% | 0.00% | – |
| Q2 2018 | $3,000 | – | 87 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 2,981,437 | $86,969,000 | 72.32% |
| MPM ASSET MANAGEMENT LLC | 3,074,893 | $89,695,000 | 60.73% |
| Foresite Capital Management IV, LLC | 696,903 | $20,329,000 | 6.66% |
| NEA Management Company, LLC | 4,912,306 | $143,292,000 | 6.18% |
| RA Capital Management | 1,950,332 | $56,891,000 | 3.04% |
| Trustees of Princeton University | 47,643 | $1,390,000 | 1.96% |
| Greylock XII GP LLC | 54,749 | $1,597,000 | 1.12% |
| Baker Brothers Advisors | 2,708,200 | $78,998,000 | 0.52% |
| Perceptive Advisors | 664,186 | $19,374,000 | 0.52% |
| Sofinnova Investments, Inc. | 159,302 | $4,646,000 | 0.41% |